MODERATE TO SEVERE ASTHMA
Clinical trials for MODERATE TO SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New program helps doctors prescribe smarter asthma treatment
Disease control Recruiting nowThis study tests a program to help doctors at community health centers prescribe a recommended asthma treatment called SMART (Single Maintenance and Reliever Therapy). The program includes training, feedback, and educational tools for both doctors and patients. Researchers will t…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE4 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
New asthma pill aims to improve breathing and cut attacks
Disease control Recruiting nowThis study tests three doses of an experimental daily pill, povorcitinib, in 240 adults with moderate to severe asthma that is not well controlled by current inhalers. The main goal is to see if the drug improves lung function over 24 weeks. Researchers will also track whether it…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis study tests an experimental drug called CM326 in 230 adults with moderate to severe asthma. Participants will receive either the drug or a placebo for 52 weeks. The goal is to see if CM326 reduces severe asthma attacks and improves breathing. All participants will continue t…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC